Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Let's let bygones be bygones. And Nordisk, they've just gone through a pretty rocky succession period after Hagedorn retired. They're now on their third CEO in seven years. And the new CEO, Henry Brenham, he isn't from the pharma industry at all. He's not a scientist. He was previously the head of a lumber company. So this merger makes perfect sense. Huh.
0
💬
0
Comments
Log in to comment.
There are no comments yet.